Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Anti Human Fn14 Antibody
Abstract: [Problem] To provide an anti-human Fn14 antibody that binds to human Fn14 and blocks action mediated through human Fn14 to prevent or treat cancer cachexia. [Solution] The present inventors conducted research on anti-human Fn14 antibodies, and have provided an anti-human Fn14 antibody including a heavy chain having the amino acid sequence of SEQ ID NO: 2 and a light chain having the amino acid sequence of SEQ ID NO: 4.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
29 April 2021
Publication Number
19/2021
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
patent@depenning.com
Parent Application
Applicants
ASTELLAS PHARMA INC.
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
Inventors
1. ITO, Misato
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
2. KASHIWAGI, Risa
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
3. KAWAKAMI, Masakatsu
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202147019665-FORM 18 [07-10-2022(online)].pdf | 2022-10-07 |
| 1 | 202147019665-STATEMENT OF UNDERTAKING (FORM 3) [29-04-2021(online)].pdf | 2021-04-29 |
| 2 | 202147019665-SEQUENCE LISTING(PDF) [29-04-2021(online)].pdf | 2021-04-29 |
| 2 | 202147019665-Correspondence_GPA_11-08-2022.pdf | 2022-08-11 |
| 3 | 202147019665-SEQUENCE LISTING [29-04-2021(online)].txt | 2021-04-29 |
| 3 | 202147019665-FORM 3 [18-03-2022(online)].pdf | 2022-03-18 |
| 4 | 202147019665-PRIORITY DOCUMENTS [29-04-2021(online)].pdf | 2021-04-29 |
| 4 | 202147019665-Correspondence_Form1_17-12-2021.pdf | 2021-12-17 |
| 5 | 202147019665.pdf | 2021-10-18 |
| 5 | 202147019665-FORM 1 [29-04-2021(online)].pdf | 2021-04-29 |
| 6 | 202147019665-FORM 3 [29-09-2021(online)].pdf | 2021-09-29 |
| 6 | 202147019665-DRAWINGS [29-04-2021(online)].pdf | 2021-04-29 |
| 7 | 202147019665-FORM-26 [26-07-2021(online)].pdf | 2021-07-26 |
| 7 | 202147019665-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2021(online)].pdf | 2021-04-29 |
| 8 | 202147019665-Proof of Right [02-06-2021(online)].pdf | 2021-06-02 |
| 8 | 202147019665-COMPLETE SPECIFICATION [29-04-2021(online)].pdf | 2021-04-29 |
| 9 | 202147019665-Proof of Right [02-06-2021(online)].pdf | 2021-06-02 |
| 9 | 202147019665-COMPLETE SPECIFICATION [29-04-2021(online)].pdf | 2021-04-29 |
| 10 | 202147019665-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2021(online)].pdf | 2021-04-29 |
| 10 | 202147019665-FORM-26 [26-07-2021(online)].pdf | 2021-07-26 |
| 11 | 202147019665-FORM 3 [29-09-2021(online)].pdf | 2021-09-29 |
| 11 | 202147019665-DRAWINGS [29-04-2021(online)].pdf | 2021-04-29 |
| 12 | 202147019665.pdf | 2021-10-18 |
| 12 | 202147019665-FORM 1 [29-04-2021(online)].pdf | 2021-04-29 |
| 13 | 202147019665-PRIORITY DOCUMENTS [29-04-2021(online)].pdf | 2021-04-29 |
| 13 | 202147019665-Correspondence_Form1_17-12-2021.pdf | 2021-12-17 |
| 14 | 202147019665-SEQUENCE LISTING [29-04-2021(online)].txt | 2021-04-29 |
| 14 | 202147019665-FORM 3 [18-03-2022(online)].pdf | 2022-03-18 |
| 15 | 202147019665-SEQUENCE LISTING(PDF) [29-04-2021(online)].pdf | 2021-04-29 |
| 15 | 202147019665-Correspondence_GPA_11-08-2022.pdf | 2022-08-11 |
| 16 | 202147019665-STATEMENT OF UNDERTAKING (FORM 3) [29-04-2021(online)].pdf | 2021-04-29 |
| 16 | 202147019665-FORM 18 [07-10-2022(online)].pdf | 2022-10-07 |